Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: Drug screen optimization and correlation with patient response

被引：0
|
作者：
Smabers, L. P. [1 ]
Wensink, E. [1 ]
Verissimo, C. S. [2 ]
Koedoot, E. [2 ]
Doorn, M. [2 ]
Pitsa, K-C. [2 ]
Huismans, M. [3 ]
Baron, C. Higuera
Valkenburg-van Iersel, L. [4 ]
Brousali, A. [5 ]
Overmeer, R. [2 ]
Braat, M. [6 ]
Elias, S. [7 ]
Vries, R. [2 ]
Kranenburg, O. [8 ]
Koopman, M. [1 ]
Boj, S. [2 ]
Roodhart, J. M. L. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Med Oncol Dept, Utrecht, Netherlands
[2] HUB Organoids, Oncol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands
[4] Maastricht Univ, Med Oncol Dept, Med Ctr, Maastricht, Netherlands
[5] Univ Med Ctr Utrecht, Utrecht Platform Organoid Technol UPORT, Utrecht, Netherlands
[6] Univ Med Ctr Utrecht, Radiol Dept, Utrecht, Netherlands
[7] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[8] Univ Med Ctr Utrecht, Surg Oncol Dept, Utrecht, Netherlands
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1286
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2258P
引用
收藏
页码：S1161 / S1162
页数：2
相关论文
共 50 条
  • [41] Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma
    George M. Ramzy
    Maxim Norkin
    Thibaud Koessler
    Lionel Voirol
    Mathieu Tihy
    Dina Hany
    Thomas McKee
    Frédéric Ris
    Nicolas Buchs
    Mylène Docquier
    Christian Toso
    Laura Rubbia-Brandt
    Gaetan Bakalli
    Stéphane Guerrier
    Joerg Huelsken
    Patrycja Nowak-Sliwinska
    Journal of Experimental & Clinical Cancer Research, 42
  • [42] Platform combining statistical modeling and patient-derived organoids to facilitate personalized treatment of colorectal carcinoma
    Ramzy, George M.
    Norkin, Maxim
    Koessler, Thibaud
    Voirol, Lionel
    Tihy, Mathieu
    Hany, Dina
    McKee, Thomas
    Ris, Frederic
    Buchs, Nicolas
    Docquier, Mylene
    Toso, Christian
    Rubbia-Brandt, Laura
    Bakalli, Gaetan
    Guerrier, Stephane
    Huelsken, Joerg
    Nowak-Sliwinska, Patrycja
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [43] Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction
    Papaccio, Federica
    Garcia-Mico, Blanca
    Gimeno-Valiente, Francisco
    Cabeza-Segura, Manuel
    Gambardella, Valentina
    Gutierrez-Bravo, Maria Fernanda
    Alfaro-Cervello, Clara
    Martinez-Ciarpaglini, Carolina
    Rentero-Garrido, Pilar
    Zuniga-Trejos, Sheila
    Carbonell-Asins, Juan Antonio
    Fleitas, Tania
    Rosello, Susana
    Huerta, Marisol
    del Pino, Manuel M. Sanchez M.
    Sabater, Luis
    Roda, Desamparados
    Tarazona, Noelia
    Cervantes, Andres
    Castillo, Josefa
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [44] “Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”
    Federica Papaccio
    Blanca García-Mico
    Francisco Gimeno-Valiente
    Manuel Cabeza-Segura
    Valentina Gambardella
    María Fernanda Gutiérrez-Bravo
    Clara Alfaro-Cervelló
    Carolina Martinez-Ciarpaglini
    Pilar Rentero-Garrido
    Sheila Zúñiga-Trejos
    Juan Antonio Carbonell-Asins
    Tania Fleitas
    Susana Roselló
    Marisol Huerta
    Manuel M. Sánchez del Pino
    Luís Sabater
    Desamparados Roda
    Noelia Tarazona
    Andrés Cervantes
    Josefa Castillo
    Journal of Experimental & Clinical Cancer Research, 42
  • [45] Biomarker-guided implementation of the old drug temozolomide as a novel treatment option for patients with metastatic colorectal cancer
    Pietrantonio, Filippo
    Randon, Giovanni
    Romagnoli, Dario
    Di Donato, Samantha
    Benelli, Matteo
    de Braud, Filippo
    CANCER TREATMENT REVIEWS, 2020, 82
  • [46] Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
    Jones, M. R.
    Schrader, K. A.
    Shen, Y.
    Pleasance, E.
    Ch'ng, C.
    Dar, N.
    Yip, S.
    Renouf, D. J.
    Schein, J. E.
    Mungall, A. J.
    Zhao, Y.
    Moore, R.
    Ma, Y.
    Sheffield, B. S.
    Ng, T.
    Jones, S. J. M.
    Marra, M. A.
    Laskin, J.
    Lim, H. J.
    ANNALS OF ONCOLOGY, 2016, 27 (05) : 801 - 806
  • [47] A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids
    Dexter Kai Hao Thng
    Lissa Hooi
    Bei En Siew
    Kai-Yin Lee
    Ian Jse-Wei Tan
    Bettina Lieske
    Norman Sihan Lin
    Alfred Wei Chieh Kow
    Shi Wang
    Masturah Bte Mohd Abdul Rashid
    Chermaine Ang
    Jasmin Jia Min Koh
    Tan Boon Toh
    Ker-Kan Tan
    Edward Kai-Hua Chow
    npj Precision Oncology, 8
  • [48] A functional personalised oncology approach against metastatic colorectal cancer in matched patient derived organoids
    Thng, Dexter Kai Hao
    Hooi, Lissa
    Siew, Bei En
    Lee, Kai-Yin
    Tan, Ian Jse-Wei
    Lieske, Bettina
    Lin, Norman Sihan
    Kow, Alfred Wei Chieh
    Wang, Shi
    Rashid, Masturah Bte Mohd Abdul
    Ang, Chermaine
    Koh, Jasmin Jia Min
    Toh, Tan Boon
    Tan, Ker-Kan
    Chow, Edward Kai-Hua
    NPJ PRECISION ONCOLOGY, 2024, 8 (01)
  • [49] High-dose short-term osimertinib treatment is effective in patient-derived metastatic colorectal cancer organoids
    Kirti K. Iyer
    Dennis Poel
    Anne Miggelenbrink
    Wouter Kerkhof
    Jorien Janssen
    Lotte Bakkerus
    Loek de Jong
    Erik van den Hombergh
    Iris D. Nagtegaal
    Daniele V. F. Tauriello
    Nielka P. van Erp
    Henk M. W. Verheul
    BJC Reports, 2 (1):
  • [50] Pharmacokinetic/pharmacodynamic modeling of biomarker response to sunitinib in patients with metastatic colorectal cancer
    Kanefendt, F.
    Lindauer, A.
    Kinzig, M.
    Strumberg, D.
    Scheulen, M.
    Fischer, R.
    Buechert, M.
    Soergel, F.
    Mross, K.
    Jaehde, U.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 550 - 550
12345